Response to netakimab in radiographic axial spondyloarthritis patients with different baseline C-reactive protein, sacroiliitis evaluated by MRI and peripheral joint involvement status: a post-hoc analysis of the ASTERA study (2023)
https://pubmed.ncbi.nlm.nih.gov/36062743/

Patient-defined flares and disease activity worsening in 222 patients with psoriatic arthritis from 14 countries (2023)
https://pubmed.ncbi.nlm.nih.gov/36529417/

Residual patient-reported burden in 444 patients with psoriatic arthritis in remission or low disease: A cross-sectional analysis (2022)
https://pubmed.ncbi.nlm.nih.gov/35257864/

Disparities in healthcare in psoriatic arthritis: an analysis of 439 patients from 13 countries (2022)
https://pubmed.ncbi.nlm.nih.gov/35523519/

Patient-defined flares and disease activity worsening in 222 patients with psoriatic arthritis from 14 countries (2022)
https://pubmed.ncbi.nlm.nih.gov/36529417/

Development of an environmental contextual factor item set relevant to global functioning and health in patients with axial spondyloarthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/34534275/

Comparative pharmacoeconomic effectiveness of interleukin-17 inhibitors for the treatment of ankylosing spondylitis (2022)
https://doi.org/10.47360/1995-4484-2022-594-601

The Level of IgA Antibodies to CD74 in Patients with Spondyloarthritis and Degenerative-Dystrophic Diseases of the Spine (2022)
https://doi.org/10.20514/2226-6704-2022-12-4-310-315

Etanercept in axial spondyloarthritis – treatment efficacy (2022)
https://pubmed.ncbi.nlm.nih.gov/36529417/

Mazurov V.I., Gaydukova I.Z., Vasilenko E.A., Vasilenko E.A., Lapin S.V., Lapin S.V., Kholopova I.V., Korolev M.A. Anti-CD74 IGA antibodies, genetic polymorphisms and inflammatory activity in ankylosing spondylitis. Rheumatology Science and Practice. 2020;58(6):658-662. https://doi.org/10.47360/1995-4484-2020-658-662 (2021)
https://doi.org/10.47360/1995-4484-2020-658-662

CHARACTERISTICS OF THE PATIENTS WITH ANKYLOSING SPONDYLITIS ACHIEVED AXIAL SPONDYLOARTHRITIS REMISSION DUE TO RUSSIAN SPA GROUP DEFINITION (2021)
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Publons&SrcAuth=Publons_CEL&KeyUT=WOS:000691812200115&DestLinkType=FullRecord&DestApp=WOS_CPL

COMPARISON OF EQ-5D HEALTH STATUS IN PSORIATIC ARTHRITIS PATIENTS WITH OR WITHOUT AXIAL DISEASE: RESULTS OF SUBANALYSIS OF THE PATERA STUDY (2021)
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Publons&SrcAuth=Publons_CEL&KeyUT=WOS:000692625300538&DestLinkType=FullRecord&DestApp=WOS_CPL

NETAKIMAB EFFICACY IN ANTI-TNF-NAIVE AND ANTI-TNF-EXPERIENCED PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: RESULTS OF SUBANALYSIS OF PHASE 3 ASTERA TRIAL (2021)
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Publons&SrcAuth=Publons_CEL&KeyUT=WOS:000692649600593&DestLinkType=FullRecord&DestApp=WOS_CPL

NETAKIMAB EFFICACY IN ANTI-TNF-NAIVE AND ANTI-TNF-EXPERIENCED PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: RESULTS OF SUBANALYSIS OF PHASE 3 ASTERA TRIAL (2021)
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Publons&SrcAuth=Publons_CEL&KeyUT=WOS:000692649600593&DestLinkType=FullRecord&DestApp=WOS_CPL

NETAKIMAB REDUCES ANKYLOSING SPONDYLITIS ACTIVITY IN PATIENTS WITH OR WITHOUT SACROILIITS ON MRI: RESULTS OF SUBANALYSIS OF PHASE 3 ASTERA TRIAL (2021)
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Publons&SrcAuth=Publons_CEL&KeyUT=WOS:000692629300140&DestLinkType=FullRecord&DestApp=WOS_CPL

NETAKIMAB REDUCES PSORIATIC ARTHRITIS ACTIVITY IN PATIENTS WITH OR WITHOUT AXIAL DISEASE: SUBANALYSIS OF THE PATERA STUDY (2021)
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Publons&SrcAuth=Publons_CEL&KeyUT=WOS:000692649600706&DestLinkType=FullRecord&DestApp=WOS_CPL

ONLINE QUESTIONNAIRE IN AXSPA DIAGNOSTICS (2021)
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Publons&SrcAuth=Publons_CEL&KeyUT=WOS:000691812200104&DestLinkType=FullRecord&DestApp=WOS_CPL

THE IMPACT OF AXIAL INVOLVEMENT ON ACR RESPONSE IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS OF SUBANALYSIS OF THE PATERA STUDY (2021)
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Publons&SrcAuth=Publons_CEL&KeyUT=WOS:000692625300532&DestLinkType=FullRecord&DestApp=WOS_CPL

THE INCONSISTENCY IN THE ASSESSMENT OF SACROILIAC JOINTS MRI PERFORMED BY A BLINDED AND UNBLINDED RHEUMATOLOGISTS AND A RADIOLOGISTS AFTER AND WITHOUT SPECIAL MRI TRAINING (2021)
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Publons&SrcAuth=Publons_CEL&KeyUT=WOS:000692625300514&DestLinkType=FullRecord&DestApp=WOS_CPL

THE PROBLEMS OF MAGNETIC RESONANCE TOMOGRAPHY DIAGNOSTICS OF PATIENTS WITH AXIAL SPONDYLO-ARTHRITIS (2021)
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Publons&SrcAuth=Publons_CEL&KeyUT=WOS:000691812200214&DestLinkType=FullRecord&DestApp=WOS_CPL

Anti-CD74 IGA antibodies, genetic polymorphisms and inflammatory activity in ankylosing spondylitis (2021)
https://doi.org/10.47360/1995-4484-2020-658-662

Determinants of sleep impairment in psoriatic arthritis: An observational study with 396 patients from 14 countries. Palominos PE, Coates L, Kohem CL, Orbai AM, Smolen J, de Wit M, Kiltz U, Leung YY, Cañete JD, Scrivo R, Balanescu A, Dernis E, Meisalu S, Soubrier M, Aydin SZ, Gaydukova I, Kalyoncu U, Gossec L. Joint Bone Spine. 2020 Oct;87(5):449-454. doi: 10.1016/j.jbspin.2020.03.014. Epub 2020 Apr 10. PMID: 32283280 (2020)
https://doi.org/10.1016/j.jbspin.2020.03.014

Determinants of Patient-Reported Psoriatic Arthritis Impact of Disease: An Analysis of the Association With Sex in 458 Patients From Fourteen Countries. Orbai AM, Perin J, Gorlier C, Coates LC, Kiltz U, Leung YY, Palominos PE, Cañete JD, Scrivo R, Balanescu A, Dernis E, Tälli S, Ruyssen-Witrand A, Soubrier M, Aydin S, Eder L, Gaydukova I, Lubrano E, Kalyoncu U, Richette P, Husni ME, Smolen JS, de Wit M, Gossec L. Arthritis Care Res (Hoboken). 2020 Dec;72(12):1772-1779. doi: 10.1002/acr.24090. PMID: 31609525 (2020)
https://doi.org/10.1002/acr.24090

Dubinina T.V., Gaydukova I.Z., Sokolova V.D., Mladov V.V., Tolkacheva D.G. Efficacy and safety of biologics for the treatment of ankylosing spondylitis: systematic literature review and network meta-analysis of treatments registered in the Russian Federation. Rheumatology Science and Practice. 2020;58(6):646-657. https://doi.org/10.47360/1995-4484-2020-646-657 (2020)
https://doi.org/10.47360/1995-4484-2020-646-657

Efficacy and safety of netakimab in patients with psoriatic arthritis: results of the phase III PATERA clinical study (2020)
https://doi.org/10.47360/1995-4484-2020-480-488

Efficacy and safety of netakimab, anti-IL-17A monoclonal antibody, in patients with ankylosing spondylitis. Results of phase III international, multicenter, randomized double-blind clinical trial BCD-085-5/ASTERA (2020)
https://doi.org/10.47360/1995-4484-2020-376-386

Osteomalation under the mask of spondyloarthritis (2020)
https://doi.org/10.17650/1818-8338-2019-13-3-4-59-66

Gaydukova IZ, Mazurov VI. The efficacy of non-sreroidal anti-inflammatory drugs. S.S. Korsakov Journal of Neurology and Psychiatry = Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2019;119(5):134-140. (2019)
https://doi.org/10.17116/jnevro2019119051134

Erdes Sh.F., Rebrov A.P., Dubinina T.V., et al. Spondyloarthritis: modern terminology and definitions. Therapeutic Archive. 2019; 91 (5): 84–88. DOI: 10.26442/00403660.2019.05.000208 (2019)
https://ter-arkhiv.ru/0040-3660/article/view/33624

Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countries. Gorlier C, Orbai AM, Puyraimond-Zemmour D, Coates LC, Kiltz U, Leung YY, Palominos P, Cañete JD, Scrivo R, Balanescu A, Dernis E, Tälli S, Ruyssen-Witrand A, Soubrier M, Aydin SZ, Eder L, Gaydukova I, Lubrano E, Kalyoncu U, Richette P, Husni ME, de Wit M, Smolen JS, Gossec L. Ann Rheum Dis. 2019 Feb;78(2):201-208. doi: 10.1136/annrheumdis-2018-214140. Epub 2018 Nov 15. (2019)
https://pubmed-gke.ncbi.nlm.nih.gov/30442648/

Gaidukova I.Z., Akulova A.I., Rebrov A.P., Bochkova A.G., Startsev S.Y., Erdes S., Gaidukova E.K., Poddubny D.A. Adaptation of the Russian version of the ASAS health index. Rheumatology Science and Practice. 2019;57(1):56-61. (In Russ.) https://doi.org/10.14412/1995-4484-2019-56-61 (2019)
https://doi.org/10.14412/1995-4484-2019-56-61

Gaidukova I.Z., Akulova A.I., Rebrov A.P., Bochkova A.G., Startsev S.Y., Erdes S., Gaidukova E.K., Poddubny D.A. Adaptation of the Russian version of the ASAS health index. Rheumatology Science and Practice. 2019;57(1):56-61. (In Russ.) https://doi.org/10.14412/1995-4484-2019-56-61 (2019)
https://doi.org/10.14412/1995-4484-2019-56-61

Effectiveness of the tenoxicam in patients with ankylosing spondylitis I.Z. GAYDUKOVA, A.V. APARKINA, E.V. KHONDKARYAN, A.P. REBROV.https://doi.org/10.17116/jnevro20181182135-39 (2018)
https://doi.org/10.17116/jnevro20181182135-39

Gaydukova I.Z., Akulova A.I., Rebrov A.P. Comorbidities in inflammatory joint and spine diseases in XXI century // Terapevticheskii arkhiv. – 2018. – Vol. 90. – N. 12. – P. 90-95. doi: 10.26442/00403660.2018.12.000015 (2018)
https://ter-arkhiv.ru/0040-3660/article/view/32927

[The clinical diagnostic significance of auto antibodies to CD74 at axial spondylarthritis.]. Kuznetsova DA, Lapin SV, Gaydukova IZ, Rebrov AP, Maslyansky AL. Klin Lab Diagn. 2018;63(5):297-301. doi: 10.18821/0869-2084-2018-63-5-297-301. PMID: 30689325 (2018)
https://pubmed-gke.ncbi.nlm.nih.gov/30689325/

Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis. Kiltz U, van der Heijde D, Boonen A, Akkoc N, Bautista-Molano W, Burgos-Vargas R, Wei JC, Chiowchanwisawakit P, Dougados M, Duruoz MT, Elzorkany BK, Gaydukova I, Gensler LS, Gilio M, Grazio S, Gu J, Inman RD, Kim TJ, Navarro-Compan V, Marzo-Ortega H, Ozgocmen S, Pimentel Dos Santos F, Schirmer M, Stebbings S, Van den Bosch FE, van Tubergen A, Braun J. Ann Rheum Dis. 2018 Sep;77(9):1311-1317. doi: 10.1136/annrheumdis-2017-212076. Epub 2018 Jun (2018)
https://pubmed-gke.ncbi.nlm.nih.gov/29858176/

Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis. Kiltz U, van der Heijde D, Boonen A, Akkoc N, Bautista-Molano W, Burgos-Vargas R, Wei JC, Chiowchanwisawakit P, Dougados M, Duruoz MT, Elzorkany BK, Gaydukova I, Gensler LS, Gilio M, Grazio S, Gu J, Inman RD, Kim TJ, Navarro-Compan V, Marzo-Ortega H, Ozgocmen S, Pimentel Dos Santos F, Schirmer M, Stebbings S, Van den Bosch FE, van Tubergen A, Braun J. Ann Rheum Dis. 2018 Sep;77(9):1311-1317. doi: 10.1136/annrheumdis-2017-212076. Epub 2018 Jun (2018)
https://pubmed-gke.ncbi.nlm.nih.gov/29858176/

Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis. Kiltz U, van der Heijde D, Boonen A, Akkoc N, Bautista-Molano W, Burgos-Vargas R, Wei JC, Chiowchanwisawakit P, Dougados M, Duruoz MT, Elzorkany BK, Gaydukova I, Gensler LS, Gilio M, Grazio S, Gu J, Inman RD, Kim TJ, Navarro-Compan V, Marzo-Ortega H, Ozgocmen S, Pimentel Dos Santos F, Schirmer M, Stebbings S, Van den Bosch FE, van Tubergen A, Braun J. Ann Rheum Dis. 2018 Sep;77(9):1311-1317. doi: 10.1136/annrheumdis-2017-212076. Epub 2018 Jun (2018)
https://pubmed-gke.ncbi.nlm.nih.gov/29858176/

[Stable high interleukin-17A concentration in patients with ankylosing spondylitis treated with tumor necrosis factor-α inhibitors during a year]. Gaydukova IZ, Rebrov AP, Aparkina AV, Khondkaryan EV. Ter Arkh. 2017;89(4):80-85. doi: 10.17116/terarkh201789480-85. (2017)
https://pubmed-gke.ncbi.nlm.nih.gov/28514405/

[Biomarkers of bone remodeling in ankylosing spondylitis patients using nonsteroidal anti-inflammatory drugs: results of an ETHICS research program]. Gaydukova IZ, Aparkina AV, Khondkaryan EV, Rebrov AP. Ter Arkh. 2017;89(12. Vyp. 2):185-189. doi: 10.17116/terarkh20178912185-189. (2017)
https://pubmed-gke.ncbi.nlm.nih.gov/29488479/

An Assessment in SpondyloArthritis International Society (ASAS)-endorsed definition of clinically important worsening in axial spondyloarthritis based on ASDAS. Molto A, Gossec L, Meghnathi B, Landewé RBM, van der Heijde D, Atagunduz P, Elzorkany BK, Akkoc N, Kiltz U, Gu J, Wei JCC, Dougados M; ASAS-FLARE study group. Ann Rheum Dis. 2018 Jan;77(1):124-127. doi: 10.1136/annrheumdis-2017-212178. Epub 2017 Oct 16. (2017)
https://pubmed-gke.ncbi.nlm.nih.gov/29038299/

[Efficiency of different celecoxib regimens in patients with active axial spondyloarthritis: Results of the 4-week pilot open-label comparative single-center study ‘AIM’]. Gaydukova IZ, Gamayunova КA, Dorogoykina KD, Rebrov AP. Ter Arkh. 2017;89(6):78-83. doi: 10.17116/terarkh201789678-83. (2017)
https://pubmed-gke.ncbi.nlm.nih.gov/28745693/

Changes in the serum concentrations of adhesion molecules and vascular endothelial growth factor in active ankylosing spondylitis patients taking amtolmetin guacil: Results of a 56-week prospective ореn-label controlled observational study]. Gaydukova IZ, Khondkaryan EV, Aparkina AV, Rebrov AP. Ter Arkh. 2017;89(5):38-45. doi: 10.17116/terarkh201789538-45. (2017)
https://pubmed-gke.ncbi.nlm.nih.gov/28631697/

Measuring impairments of functioning and health in patients with axial spondyloarthritis by using the ASAS Health Index and the Environmental Item Set: translation and cross-cultural adaptation into 15 languages. Kiltz U, van der Heijde D, Boonen A, Bautista-Molano W, Burgos-Vargas R, Chiowchanwisawakit P, Duruoz T, El-Zorkany B, Essers I, Gaydukova I, Géher P, Gossec L, Grazio S, Gu J, Khan MA, Kim TJ, Maksymowych WP, Marzo-Ortega H, Navarro-Compán V, Olivieri I, Patrikos D, Pimentel-Santos FM, Schirmer M, van den Bosch F, Weber U, Zochling J, Braun J. RMD Open. 2016 Oct 4;2(2):e000311. doi: 10.1136/rmdopen-2016-000311. eCollection 2016. (2016)
https://pubmed-gke.ncbi.nlm.nih.gov/27752358/

[Efficiency and safety of different etoricoxib regimens in patients with axial spondyloarthritis, including ankylosing spondylitis]. Gaydukova IZ, Rebrov AP. Ter Arkh. 2015;87(3):77-82. doi: 10.17116/terarkh201587377-82. (2015)
https://pubmed-gke.ncbi.nlm.nih.gov/26027245/

Efficacy and safety of intravenous methylprednisolone in the treatment of patients with active ankylosing spondylitis: results of a 12-week, prospective, open-label, pilot (METALL) study]. Gaydukova IZ, Rebrov AP, Poddubnyi DA. Ter Arkh. 2015;87(5):47-52. doi: 10.17116/terarkh201587547-52. (2015)
https://pubmed-gke.ncbi.nlm.nih.gov/26155618/

Compliance to treatment and effectiveness of therapy in different regimes of monitoring activity of patients with axial spondyloarthritis]. Gaĭdukova IZ, Akulova AI, Aparkina AV, Rebrov AP. Klin Med (Mosk). 2014;92(10):60-5. (2014)
https://pubmed-gke.ncbi.nlm.nih.gov/?term=Gaidukova

Magnetic resonance imaging compared to conventional radiographs for detection of chronic structural changes in sacroiliac joints in axial spondyloarthritis. Poddubnyy D, Gaydukova I, Hermann KG, Song IH, Haibel H, Braun J, Sieper J. J Rheumatol. 2013 Sep;40(9):1557-65. doi: 10.3899/jrheum.130141. Epub 2013 Jul 1. PMID: 23818713 (2013)
https://pubmed-gke.ncbi.nlm.nih.gov/23818713/

Decreased heart rate variability in patients with psoriatic arthritis. Gaydukova I, Rebrov A, Nikitina N, Poddubnyy D. Clin Rheumatol. 2012 Sep;31(9):1377-81. doi: 10.1007/s10067-012-2015-3. Epub 2012 Jun 7. (2012)
https://pubmed-gke.ncbi.nlm.nih.gov/22673792/